ASH 2022 Conference Coverage
ASH 2022 SubQ Isatuximab + Carfilzomib & Dexamethasone in Relapsed MM: Ikema Subgroup Analysis by Number of Prior Lines of Treatment
By
ASH 2022 Conference Coverage
FEATURING
Hang Quach
By
ASH 2022 Conference Coverage
FEATURING
Hang Quach
Login to view comments.
Click here to Login